You are here
Articles
Posted on Wednesday, November 16, 2011 - 1:51pm
Apparently the link I posted seems to have a problem. This article is free so I have posted the link below. You just need to click on the button which say access this article for free and it should take you to the...
Posted on Tuesday, November 15, 2011 - 11:52am
Press release: 25th September 2011. Vaxil BioTherapeutics Ltd. a clinical-stage vaccine development company announced today that it has submitted a patent application to the United States Patent Office...
Posted on Sunday, November 13, 2011 - 7:06pm
Leukemia , (11 November 2011) | doi:10.1038/leu.2011.323
Posted on Friday, November 11, 2011 - 1:22pm
Variant Philadelphia (Ph) chromosome translocations have been reported in 5%-10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant translocations may involve one or more chromosomes in addition to...
Posted on Friday, November 11, 2011 - 1:14pm
STIM Study Examines Sustainability of Complete Molecular Response After Stopping Imatinib in CML
Elsevier Global Medical News. 2010 Jan 13, P Wendling
Posted on Thursday, November 3, 2011 - 11:23am
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised...
Posted on Saturday, September 24, 2011 - 8:23pm
Posted on Wednesday, August 24, 2011 - 1:49pm
A pivotal Phase 2 clinical trial of ARIAD’s investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), is ongoing in patients with resistant or intolerant chronic myeloid leukemia...
Posted on Saturday, August 6, 2011 - 3:09pm
This is a really interesting interview with Hagop Kantarjian of MDACC, Houston where he talks about the current therapies for CML. He has an interesting view on 2nd generation TKI in front line treatment and how that...
Posted on Tuesday, August 2, 2011 - 10:01pm
Dr Andrew Goringe, Consultant Haematologist in Cardiff recommends that you 'save the date' for this years annual CML patient/carer day on 12 November 2011 in Cardiff.
Posted on Saturday, June 25, 2011 - 7:47pm
In May, 2011, 30 scientists from 14 countries met at the International
Agency for Research on Cancer (IARC) in Lyon, France, to assess the carcinogenicity of radiofrequency electromagnetic fields (RF-EMF).
Posted on Friday, June 24, 2011 - 12:01pm
Bafetinib (formerly known as INNO-406) is an orally bioavailable, rationally designed, dual Bcr-Abl and Lyn-kinase inhibitor. According to a study published in the journal Blood (Dec. 1, 2005), bafetinib is 25 to 55...
Posted on Friday, June 17, 2011 - 10:29am
Simona Soverini1,*, Andreas Hochhaus2, Franck E Nicolini3, Franz Gruber4, Thoralf Lange5, Giuseppe Saglio6, Fabrizio Pane7, Martin C Müller8, Thomas Ernst2, Gianantonio Rosti1, Kimmo Porkka9, Michele Baccarani1,...
Posted on Friday, June 10, 2011 - 12:34pm
Cancer drug protest
2.58PM Thu Jun 9 2011
- ‹ previous
- 21 of 33
- next ›